JS BIOFUTURE INVEST ApS: Financial statements 2023
CVR: 31080983
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -15,348 and a net result of DKK -24,077 compared with DKK -5,118 the year before. Equity in the 2023 report amounted to DKK 223,115. The solvency ratio was 26.7%.
- Gross Profit
- DKK -15,348
- Profit/Loss
- DKK -24,077
- Equity
- DKK 223,115
- Total Assets
- DKK 834,863
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -15K | -24K | 223K | - |
| 2022 | - | -14K | -5K | 247K | 0 |
| 2021 | - | -66K | -45K | 252K | - |
| 2020 | - | -17K | 120K | 297K | - |
| 2019 | - | -6K | 39K | 52K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
JS BIOFUTURE INVEST ApS has published its annual report for 2022. Gross profit came to DKK -13,564, and the net result was DKK -5,118.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.